Neurotransmitters partially restore glucose sensitivity of insulin and glucagon secretion from perfused streptozotocin-induced diabetic rat pancreas

K. Ito, Hiroshi Hirose, H. Maruyama, S. Fukamachi, Y. Tashiro, T. Saruta

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

To elucidate the mechanisms of insensitivity of hormone secretion to glucose in streptozotocin-induced diabetic rat islets, we investigated the effects of acetylcholine (ACh) and norepinephrine on insulin and glucagon secretion in response to changes in glucose concentration, using perfused pancreas preparations. Basal insulin secretion at a blood glucose level of 5.6 mmol/l was significantly higher and basal glucagon secretion significantly lower in streptozotocin-induced diabetic rats than in controls, and neither high (16.7 mmol/l) nor low (1.4 mmol/l) blood glucose concentrations influenced insulin or glucagon secretion. Addition of 10-6 mol/l ACh to the perfusate increased glucose-stimulated insulin secretion. Also, 10-6 mol/l ACh, 10-7 mol/l norepinephrine, as well as a combination of both, induced marked glucagon secretion, this was suppressed by high blood glucose level. Although simultaneous addition of 10-6 mol/l ACh and 10-7 mol/l norepinephrine induced only a slight increase in glucagon secretion in response to glucopenia, there was a significant increase in glucagon secretion in conjunction with an ambient decrease in insulin. Histopathological examination revealed a marked decline in acetylcholinesterase and monoamine-oxidase activities in the islets of streptozotocin-induced diabetic rats. We speculate that reduction of the potentiating effects of ACh and norepinephrine lessens glucose sensitivity of islet beta and alpha cells in this rat model of diabetes.

Original languageEnglish
Pages (from-to)1276-1284
Number of pages9
JournalDiabetologia
Volume38
Issue number11
DOIs
Publication statusPublished - 1995 Nov

Fingerprint

Streptozocin
Glucagon
Neurotransmitter Agents
Insulin Resistance
Pancreas
Acetylcholine
Glucose
Insulin
Norepinephrine
Blood Glucose
Monoamine Oxidase
Acetylcholinesterase
Hormones

Keywords

  • Acetylcholine
  • diabetes mellitus
  • glucagon
  • insulin
  • norepinephrine

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Neurotransmitters partially restore glucose sensitivity of insulin and glucagon secretion from perfused streptozotocin-induced diabetic rat pancreas. / Ito, K.; Hirose, Hiroshi; Maruyama, H.; Fukamachi, S.; Tashiro, Y.; Saruta, T.

In: Diabetologia, Vol. 38, No. 11, 11.1995, p. 1276-1284.

Research output: Contribution to journalArticle

@article{e91da91c82f64f0da87d32fa599c3ba1,
title = "Neurotransmitters partially restore glucose sensitivity of insulin and glucagon secretion from perfused streptozotocin-induced diabetic rat pancreas",
abstract = "To elucidate the mechanisms of insensitivity of hormone secretion to glucose in streptozotocin-induced diabetic rat islets, we investigated the effects of acetylcholine (ACh) and norepinephrine on insulin and glucagon secretion in response to changes in glucose concentration, using perfused pancreas preparations. Basal insulin secretion at a blood glucose level of 5.6 mmol/l was significantly higher and basal glucagon secretion significantly lower in streptozotocin-induced diabetic rats than in controls, and neither high (16.7 mmol/l) nor low (1.4 mmol/l) blood glucose concentrations influenced insulin or glucagon secretion. Addition of 10-6 mol/l ACh to the perfusate increased glucose-stimulated insulin secretion. Also, 10-6 mol/l ACh, 10-7 mol/l norepinephrine, as well as a combination of both, induced marked glucagon secretion, this was suppressed by high blood glucose level. Although simultaneous addition of 10-6 mol/l ACh and 10-7 mol/l norepinephrine induced only a slight increase in glucagon secretion in response to glucopenia, there was a significant increase in glucagon secretion in conjunction with an ambient decrease in insulin. Histopathological examination revealed a marked decline in acetylcholinesterase and monoamine-oxidase activities in the islets of streptozotocin-induced diabetic rats. We speculate that reduction of the potentiating effects of ACh and norepinephrine lessens glucose sensitivity of islet beta and alpha cells in this rat model of diabetes.",
keywords = "Acetylcholine, diabetes mellitus, glucagon, insulin, norepinephrine",
author = "K. Ito and Hiroshi Hirose and H. Maruyama and S. Fukamachi and Y. Tashiro and T. Saruta",
year = "1995",
month = "11",
doi = "10.1007/BF00401759",
language = "English",
volume = "38",
pages = "1276--1284",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "11",

}

TY - JOUR

T1 - Neurotransmitters partially restore glucose sensitivity of insulin and glucagon secretion from perfused streptozotocin-induced diabetic rat pancreas

AU - Ito, K.

AU - Hirose, Hiroshi

AU - Maruyama, H.

AU - Fukamachi, S.

AU - Tashiro, Y.

AU - Saruta, T.

PY - 1995/11

Y1 - 1995/11

N2 - To elucidate the mechanisms of insensitivity of hormone secretion to glucose in streptozotocin-induced diabetic rat islets, we investigated the effects of acetylcholine (ACh) and norepinephrine on insulin and glucagon secretion in response to changes in glucose concentration, using perfused pancreas preparations. Basal insulin secretion at a blood glucose level of 5.6 mmol/l was significantly higher and basal glucagon secretion significantly lower in streptozotocin-induced diabetic rats than in controls, and neither high (16.7 mmol/l) nor low (1.4 mmol/l) blood glucose concentrations influenced insulin or glucagon secretion. Addition of 10-6 mol/l ACh to the perfusate increased glucose-stimulated insulin secretion. Also, 10-6 mol/l ACh, 10-7 mol/l norepinephrine, as well as a combination of both, induced marked glucagon secretion, this was suppressed by high blood glucose level. Although simultaneous addition of 10-6 mol/l ACh and 10-7 mol/l norepinephrine induced only a slight increase in glucagon secretion in response to glucopenia, there was a significant increase in glucagon secretion in conjunction with an ambient decrease in insulin. Histopathological examination revealed a marked decline in acetylcholinesterase and monoamine-oxidase activities in the islets of streptozotocin-induced diabetic rats. We speculate that reduction of the potentiating effects of ACh and norepinephrine lessens glucose sensitivity of islet beta and alpha cells in this rat model of diabetes.

AB - To elucidate the mechanisms of insensitivity of hormone secretion to glucose in streptozotocin-induced diabetic rat islets, we investigated the effects of acetylcholine (ACh) and norepinephrine on insulin and glucagon secretion in response to changes in glucose concentration, using perfused pancreas preparations. Basal insulin secretion at a blood glucose level of 5.6 mmol/l was significantly higher and basal glucagon secretion significantly lower in streptozotocin-induced diabetic rats than in controls, and neither high (16.7 mmol/l) nor low (1.4 mmol/l) blood glucose concentrations influenced insulin or glucagon secretion. Addition of 10-6 mol/l ACh to the perfusate increased glucose-stimulated insulin secretion. Also, 10-6 mol/l ACh, 10-7 mol/l norepinephrine, as well as a combination of both, induced marked glucagon secretion, this was suppressed by high blood glucose level. Although simultaneous addition of 10-6 mol/l ACh and 10-7 mol/l norepinephrine induced only a slight increase in glucagon secretion in response to glucopenia, there was a significant increase in glucagon secretion in conjunction with an ambient decrease in insulin. Histopathological examination revealed a marked decline in acetylcholinesterase and monoamine-oxidase activities in the islets of streptozotocin-induced diabetic rats. We speculate that reduction of the potentiating effects of ACh and norepinephrine lessens glucose sensitivity of islet beta and alpha cells in this rat model of diabetes.

KW - Acetylcholine

KW - diabetes mellitus

KW - glucagon

KW - insulin

KW - norepinephrine

UR - http://www.scopus.com/inward/record.url?scp=0028824214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028824214&partnerID=8YFLogxK

U2 - 10.1007/BF00401759

DO - 10.1007/BF00401759

M3 - Article

C2 - 8582536

AN - SCOPUS:0028824214

VL - 38

SP - 1276

EP - 1284

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 11

ER -